KMT2A and acute lymphoblastic leukemia: MLL-rearranged infant ALL (MLL-r iALL) represents a rare but highly aggressive type of childhood leukemia that is notoriously characterized by chemotherapy resistance and high relapse rates, leading to a very poor prognosis.